Congrats man! Up over 25% in the last few weeks. Hang on to your shares for another year and you should close to a double at this price. I don't think we hit our primary target of 40% but I do think we end in the range of overall survival increase of 25-30%. This is still certainly good results but how Mr. Market responds initially is anyone's guess. Instos buying currently and may be tied in to rolling out further studies on the pre lymphoid leukemia side in the next few months. Strictly rumor on that however. No current proof that it will be reported by April but my gut feeling is that it will, Take care and hope to be back ASAP.